BIM
CYTK icon

BlackRock Investment Management’s Cytokinetics CYTK Stock Holding History

BlackRock Investment Management’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$1.63M Sell
134,303
-523
-0.4% -$5.55K ﹤0.01% 2366
2016
Q3 		$1.24M Buy
134,826
+5,440
+4% +$56.8K ﹤0.01% 2526
2016
Q2 		$1.23M Buy
129,386
+1,398
+1% +$11.5K ﹤0.01% 2479
2016
Q1 		$902K Buy
127,988
+933
+0.7% +$6.82K ﹤0.01% 2554
2015
Q4 		$1.33M Buy
127,055
+1,160
+0.9% +$11.4K ﹤0.01% 2382
2015
Q3 		$842K Sell
125,895
-3,641
-3% -$24.9K ﹤0.01% 2719
2015
Q2 		$870K Buy
129,536
+15,062
+13% +$98.8K ﹤0.01% 2877
2015
Q1 		$776K Sell
114,474
-743
-0.6% -$5.55K ﹤0.01% 2693
2014
Q4 		$923K Sell
115,217
-1,852
-2% -$7.95K ﹤0.01% 2599
2014
Q3 		$412K Buy
117,069
+3,640
+3% +$15.3K ﹤0.01% 3071
2014
Q2 		$542K Buy
113,429
+20,021
+21% +$122K ﹤0.01% 3000
2014
Q1 		$887K Buy
93,408
+16,642
+22% +$151K ﹤0.01% 2595
2013
Q4 		$499K Sell
76,766
-1,204
-2% -$7.91K ﹤0.01% 2951
2013
Q3 		$590K Buy
+77,970
New +$836K ﹤0.01% 2820

Other funds holding CYTK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BlackRock Investment Management's CYTK Position: Q4 2016 in Review

BlackRock Investment Management reduced its Cytokinetics (CYTK) stake by 0.39% in Q4 2016, selling an estimated $5.55K and leaving 134,303 shares worth $1.63M. The position accounts for ﹤0.01% of the portfolio, ranked #2366.

BlackRock Investment Management first reported a position in CYTK in Q3 2013 and has held it in 14 quarters since. 101 funds tracked by Wall St. Rank hold CYTK as of Q4 2016.

  • BlackRock Investment Management held 134,303 shares of Cytokinetics worth $1.63M as of Q4 2016.
  • BlackRock Investment Management sold 523 Cytokinetics shares in Q4 2016, an estimated $5.55K.
  • Cytokinetics made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2366 holding.
  • BlackRock Investment Management first reported a position in Cytokinetics in Q3 2013 and has held it in 14 quarters since.
  • 101 funds tracked by Wall St. Rank held Cytokinetics as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.